SCHEMBL9738503

SCHEMBL9738503

CC(C)n1nc(C(=O)NC2CCCCC2)nc1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1

nearest known ligand 0.36

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
TRPV1 Q8NER1 1/20 0.36
ALDH1A1 P00352 2/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
LMNA P02545 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
TACR2 P21452 1/20 0.36
TACR3 P29371 1/20 0.36
OPRM1 P35372 1/20 0.36
PDE6D O43924 1/20 0.35
PTGS2 P35354 1/20 0.34
USP1 O94782 1/20 0.34
GAA P10253 1/20 0.34
TSHR P16473 2/20 0.34
HTR4 Q13639 1/20 0.34
RAB9A P51151 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9738653 0.99 TRPV1 (0.35) TRPV1ALDH1A1MEN1KMT2ALMNA
SCHEMBL9737978 0.88 AGTR1 (0.34) ALDH1A1PTGS2TSHR
SCHEMBL9738134 0.87 AGTR1 (0.35) ALDH1A1
SCHEMBL9738648 0.87 RIPK1 (0.42) ALDH1A1MEN1KMT2ALMNASMN1; SMN2
SCHEMBL9740299 0.87 RIPK1 (0.42) ALDH1A1MEN1KMT2ALMNASMN1; SMN2
SCHEMBL9738796 0.87 AGTR1 (0.38)
SCHEMBL9738079 0.86 RIPK1 (0.34) TRPV1ALDH1A1MEN1KMT2ALMNA
SCHEMBL9739141 0.86 RIPK1 (0.37) TRPV1ALDH1A1MEN1KMT2ALMNA
SCHEMBL9740009 0.86 AGTR1 (0.39)
SCHEMBL9738099 0.85 RIPK1 (0.35) ALDH1A1MEN1KMT2ALMNASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1992005161-A1 1,3,5-TRISUBSTITUTED-1,2,4-TRIAZOLE COMPOUNDS FOR TREATMENT OF CIRCULATORY DISORDERS G.D. SEARLE & CO. (US) 1992-04-02 WO claimed
WO-1992005161-A1 1,3,5-TRISUBSTITUTED-1,2,4-TRIAZOLE COMPOUNDS FOR TREATMENT OF CIRCULATORY DISORDERS G.D. SEARLE & CO. (US) 1992-04-02 WO disclosed